Refine Your Strategy, Sharpen Your Positioning, & Meet the Right Partners to Accelerate Licensing & Co-development with International Partners
Whether you are advancing novel payloads to address drug resistance in ADCs, expanding T-cell engager pipelines beyond solid tumors, designing new PROTAC or MGD candidates, or advancing clinical PoC of radioligand therapeutics; the clinical and competitive challenges in today's landscape demands collaboration with pharma to access capital and international markets.
Already running in the US, the Targeted Therapies Partnering & Licensing Summit Asia is built to gather a critical mass of innovative and targeted assets, so global MNCs can efficiently meet, understand and compare opportunities for licensing and co-development. Through a dedicated one-to-one partnering system, bespoke matchmaking, and 100% alignment in research interests, biotech business development can cut through noise and competition for guaranteed meetings with key stakeholders.
What are the Sessions?
Pharma Icebreaker Discussion: Insights into Big Pharma’s Wish List
For companies looking to out-license, co-develop, and partner, hear insights into what pharma is looking for directly from business development leads to ensure you share the right information in your private meetings that follow.
Pharma Icebreaker Roundtables: Unlock Connections with MNCs
Connect and introduce yourself to the pharma business development leads on the morning of Day One, so you can organise private meetings later in the conference and build interest in your presentation during presentation sessions
One-on-One Partnering System: Schedule Individual Meetings with Other Attendees
The industry’s favorite partnering portal, search the full attendee list, message and pre-schedule meetings in calendars ahead of the conference, and automatically book private meeting spaces: the most efficient way to set yourself up for success.
Presentation Availability During “Showcase Your Science” Sessions in the Agenda
At the intersection of innovative research and business conversations, this forum supports the pitching of biotech pipelines and platforms to pharma and investors. As you register, secure a 15-minute presentation slot. There will be no conflicting content happening to ensure a full and engaged audience, listening to your presentation so you can generate interest from a large group of potential partners, and support any private conversations
Explore the Full Event Guide
- 100% alignment across research focus, business needs and individual responsibilities
- Global pharma business development panel discussion to hear pharma’s wants and needs
- Asia investors' formal networking session to understand the excitement around investing
- Informal drinks and networking reception to connect with other attendees
- Learn from peers across DCs, TPD, BsAbs, TCEs and RLTs
Who Attends?
Big Pharma
For Head of Business Development for Targeted Therapies in Asia
This forum offers the opportunity for:
- Evaluation and comparison of related assets, pipelines and platforms
- Understanding of relevant scientific context to validate innovations and support strategic decision-making
- A boutique touchpoint for follow-up outside of JPM and BIO, with more time to give detailed guidance and feedback
“The focused niche really increased the impact for us overall. Thanks for including us in the program” Roche, Speaker at US Summit
Biotech
For Founders, C-Suite, Heads of Business Development
Ensuring global exposure, with a local advantage, biotech join this different format to:
- Network more efficiently with less competitive to engage with key stakeholders
- Understand positioning and pitches of competitors to sharpen own differentiation
- Gain multiple 1-2-1 meetings for feedback on data packages to action ahead of BIO or other conferences later in the year
“The event assembled a diverse set of stakeholders extremely relevant for partnering in this specific field. It was the right size meaning organic opportunities for connections”
Biotech Attendee at US Summit
Investors
For Corporate Venture & Venture Capital
Connecting investors to both pharma and biotech teams, this unique opportunity allows investors to:
- Understand pharma’s reception to innovation developed by leading biotech to inform portfolio direction and exit strategies
- Efficiently gain landscape updates and information from private biotech
“The high seniority and high quality of participants made it easier than usual to get a meeting with the right people, primarily pharma.”
Investor Attendee at US Summit
Agenda Walk-through with Grace
We know a PDF can't tell you everything about how our partnering meetings work. That's why we want Grace to personally walk you through the agenda. You'll see how our unique blend of targeted pharma matchmaking, carefully designed networking, and an enhanced partnering platform can truly set you apart from your competitors. Just give us 4 minutes, and we'll show you exactly what this meeting can do for you.
Attending Companies Include
